Concepedia
Statistics
Publications
4
Citations
128
H-Index
Active since
1997
Affiliations
Pfizer (Japan)(Current)
Teikyo University
Pfizer (United States)
Kenji Nagino is an author at Pfizer (Japan) specializing in antifungal agents, pharmacology, and antifungal therapy.
Publications per year
1997–2002
Influence of macrolides on mucoid alginate biosynthetic enzyme from Pseudomonas aeruginosa
Kenji Nagino, Hiroyuki Kobayashi · Clinical Microbiology and Infection · 1997 · 55 citations · Full text
Life Sciences, Biotechnology, Microbiology +13
Usefulness of a colorimetric method for testing antifungal drug susceptibilities of Aspergillus species to voriconazole
Hideyo Yamaguchi, Katsuhisa Uchida, Kenji Nagino et al. · Journal of Infection and Chemotherapy · 2002 · 46 citations
Life Sciences, Microbiology, Pharmacology +16
Comparison of the therapeutic efficacy of oral doses of fluconazole and itraconazole in a guinea pig model of dermatophytosis
Kenji Nagino, Hiroshi Shimohira, Masatoshi Ogawa et al. · Journal of Infection and Chemotherapy · 2000 · 16 citations
Medicine, Dermatology, Pharmacology +16
Comparison of the Therapeutic Efficacy of Oral Doses of Fluconazole and Griseofulvin in a Guinea Pig Model of Dermatophytosis.
Kenji Nagino, Hiroshi Shimohira, Masatoshi Ogawa et al. · The Journal of Antibiotics · 2000 · 11 citations · Full text
Medicine, Dermatology, Pharmacology +15
1–4 of 4